Screener / SEC EDGAR /CIK 0001005284 /10-K filed Feb 19, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Electronic Components

Universal Display Corp \PA\ OLED

Compare with peers Embed
SEC comment letters, last 20 years

4 reviews of OLED's filings by SEC staff

UPLOAD and CORRESP
Reviews 4 latest letter Nov 7, 2023
Questions asked 10 each answered in the company's own letter
No closing letter 0 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 4 UPLOAD
  2. 2. Questions in them 10 numbered comments
  3. 3. Company replies 4 CORRESP
  4. 4. Reviews closed 4 of 4 closing letter

Half the closed reviews took 22 days or less from the first letter to the closing letter.

Form 10-K for the Fiscal Year Ended December 31, 2022

2023-11-07 to 2023-11-21 · 3 questions · 1 letter from the SEC, 1 from the company
Review closed 2023-11-21
Goodwill and impairmentRevenue
Note 2. Summary of Significant Accounting Policies · Goodwill and Purchased Intangible Assets, page F-12
SEC asked (1)
It appears that the second step of your goodwill impairment test policy is not consistent with the guidance outlined in ASC 350-20-35-8 and ASC 350-20-55-25. Please advise us if you have adopted ASU 2017-04 and, if not, how your historical accounting treatment would have been impacted had you appropriately applied such guidance.
OLED answered
We have previously adopted ASU 2017-4 and will revise future filings to properly reflect the disclosure requirements consistent with the guidance outlined in ASC 350-20-35-8 and ASC 350-20-55-25. We plan to include the following disclosure in future filings:

“If after assessing the totality of events or circumstances as those described in the qualitative assessment, it is determined that it is more likely than not the fair value of a reporting unit is less than its carrying amount, then a quantitative goodwill impairment test will be performed.
Rest of the answer

Under the quantitative test, the fair value of the reporting unit is compared to its carrying amount including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill of the reporting unit would be considered not impaired. However, if the carrying amount of the reporting unit exceeds its fair value, an impairment loss would be recognized in the amount equal to the excess, limited to the total amount of goodwill allocated to that reporting unit.”

Since adoption of ASU 2017-4, we have consistently applied the qualitative assessment (“Step 0”) of whether it is more likely than not that goodwill is impaired. We determined under Step 0, in all of the years under consideration, that it was more likely than not that the fair value of the relevant reporting unit exceeded its carrying amount, rendering the quantitative goodwill impairment test unnecessary.

Read in the reply
In its next report

First report after the company's reply of Nov 15, 2023: 10-K filed Feb 22, 2024 ↗, against the 10-K filed Feb 23, 2023 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Revenue Recognition and Deferred Revenue, page F-14
SEC asked (2)
Your revenue recognition policy disclosures indicate that technology license agreements and material supply agreements are combined as a single performance obligation and recognized over the contract term. We further note that you allocate the total contract consideration under these agreements to material sales and royalty and licensing fees on the Consolidated Statements of Income based on contract pricing.
Rest of the question

Please explain to us your basis for separating a single performance obligation into multiple line items on your income statement and within your disaggregated revenue disclosures under ASC 606-1050-5. In doing so, ensure you tell us and clarify your disclosures to specify if you have revenue arrangements that include just material sales or just royalties and license fees.

OLED answered
We respectfully refer the Staff to our previous response dated November 23, 2020, to the SEC Comment Letter dated October 19, 2020, in which we indicated that we consider our technology license agreements and material supply agreements to be a combined performance obligation, and as such, consider total consideration in the aggregate as our key decision variable when executing these contracts, not the various cash streams of which total consideration is composed.
Rest of the answer

Of the total revenue recognized for the fiscal years of 2020, 2021 and 2022, ninety-seven percent (97%) was determined by contractual arrangements with our significant customers that include fees for both material sales and intellectual property in the form of royalty and license fees. The remaining revenue arrangements were composed of material sales or contract research services revenue from our subsidiary, Adesis, Inc., which provides support services to the pharmaceutical, biotechnology and other industries on a contractual basis for those third-party customers, and the Company’s occasional material sale to less significant customers. None of the revenue recognized for the fiscal periods of 2020, 2021 or 2022 was solely for royalty and license fees.

Also, as noted in our previous response dated November 23, 2020, since our Form 10-K filing for the year ended December 31, 2020, filed on February 18, 2021 we have disclosed disaggregated revenue information with respect to material sales and royalty and license fees in our Forms 10-K and 10-Q, which information we had disclosed only in our press releases and investor presentations prior to the SEC Comment Letter dated October 19, 2020.

In formulating this approach, which we have done with attention to ASC 606-10-50-5, we note that we include the disaggregated information in both our Forms 10-K and 10-Q, as well as our press releases and our investor presentations, in response to past requests for such information by users of our financial statements. However, our chief operating decision makers utilize aggregate consideration to be received from a given contract when deciding to enter those transactions and in evaluating strategic decisions, as well as when examining the financial performance of the Company. Distinctions between material and technology license streams will vary across customers and are not key decision factors when entering into contractual arrangements with our customers. However, in consideration of the continued use of this disaggregation of material sales and royalty and license fees by readers of our press releases and investor presentations, as well as those of the Forms 10-K and 10-Q, we continue to present this disaggregation.

We plan to include the following disclosure in future filings:

“The vast majority of revenue attributed to material sales is determined through technology license agreements and material supply agreements that are jointly agreed upon with the Company’s customers. The remaining revenue recognized is in the form of contract research services revenue earned by the Company’s subsidiary, Adesis, Inc., and the Company’s occasional material sale to less significant customers. None of the revenue recognized during the fiscal years 2020, 2021 or 2022 was solely from royalty or license fee arrangements that did not have material sales associated with it.”

Read in the reply
In its next report

First report after the company's reply of Nov 15, 2023: 10-K filed Feb 22, 2024 ↗, against the 10-K filed Feb 23, 2023 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 16. Stock-based Compensation, page F-25
SEC asked (3)
You disclose that the fair value of restricted stock awards and units to non-employees is "equal to the market price at the end of the reporting period for unvested non-employee awards or upon the date of vesting for vested non-employee awards." Citing the specific accounting guidance, please tell us how your accounting treatment complies with ASC 718.
OLED answered
We adopted ASU 2018-07 in January 2019 and have since measured nonemployee share-based payment awards at the grant-date fair value. Historically, our issuances of nonemployee share-based payment awards are infrequent and not material in value. As such, we will revise future filings to properly reflect the disclosure requirements of the simplified method of accounting for nonemployee share-based payment awards consistent with the guidance outlined in ASC 718, namely “Consistent with the accounting for equity-classified awards issued to employees, our equity-classified nonemployee share-based
Rest of the answer

awards are measured at the grant date fair value.”

Read in the reply
In its next report

First report after the company's reply of Nov 15, 2023: 10-K filed Feb 22, 2024 ↗, against the 10-K filed Feb 23, 2023 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2023-11-21

Form 10-K for the Year Ended December 31, 2019

2020-10-19 to 2020-12-01 · 2 questions · 1 letter from the SEC, 1 from the company
Review closed 2020-12-01
RevenueResults discussion (MD&A)
Form 10-K for Fiscal Year Ended December 31, 2019 · Results of Operations, page 34
SEC asked (1)
You disclose the increase in revenue from fiscal 2018 to fiscal 2019 was due to higher material sales as a result of stronger demand in the OLED display market. Revise future filings to include an analysis of the known material trends, events, demands, commitments and uncertainties.
Rest of the question

In this regard, you should quantify underlying drivers or metrics to illustrate the change in demand (e.g., volume of sales such as number of orders or shipments, average sales price, impacts of material changes in variable consideration, and/or changes in disaggregated revenues, to the extent applicable). Additionally, quantify the impact of the contract referenced on page F-34, given it appears to impact revenue trends and timing of recognized revenue due to variable consideration. Please refer to SEC Release Nos. 33-6835 and 33-8350.

OLED answered
We will revise future filings to include analysis of known material trends, events, demands, commitments and uncertainties regarding pertinent elements of our financial results, including our revenue and sales results. Where applicable, we will quantify underlying drivers or metrics to illustrate changes in demand that factor into such results.

With regard to the contract referenced on page F-34, we do note on that page that the Company was constrained per

Topic 606 to recognize revenue to the extent that it was probable that a significant revenue reversal would not occur and deferred
Rest of the answer

recognition of the remainder until after uncertainties of the transaction were resolved. The impact from this transaction on our financial statements was not significant due to the appropriate application of the constraint and was reflected in a manner consistent with all other typical transactions with our customers, and as such we do not believe additional disclosure was required. In the future, all transactions that have a material impact on revenue trends and timing of recognized revenue will be quantified and disclosed as required.

Read in the reply
In its next report

First report after the company's reply of Nov 23, 2020: 10-K filed Feb 18, 2021 ↗, against the 10-K filed Feb 20, 2020 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 19. Revenue Recognition, page F-34
SEC asked (2)
Your revenue recognition policy disclosure starting on page F-13 indicates that material sales are generally recognized at the time the title passes or after control if variable consideration is present. Additionally, technology license agreements and material supply agreements are combined as a single performance obligation and recognized over the contract term based on material units sold at the estimated per unit
Rest of the question

fee over the life of the contract. Finally, we note your tabular "Revenue Comparison" disclosure in your earnings releases on Form 8-K where you disclose material sales, royalty and license fees, and contract research services. Given it appears you have two material revenue streams, tell us your consideration to disclose disaggregated revenue information in your Forms 10-Q and 10-K pursuant to ASC 606-10-50-5 to 7.

OLED answered
As noted in the Staff’s comment, we consider our technology license agreements and material supply agreements as a combined performance obligation and as such consider total consideration in the aggregate as our key decision variable when executing these contracts, not the various cash streams of which total consideration is comprised.
Rest of the answer

We also note that we do disclose what we believe are relevant factors for disaggregation, such as revenue by largest customers and geographic location in Footnote 17 and revenue by our subsidiary in Footnote 19, as we believe these are important indicators of company performance and financial trends.

We are cognizant that we present disaggregated disclosure with respect to material sales and royalty and license fees in our press releases and investor presentations, while we do not do so in our Forms 10-K and 10-Q. In formulating this approach, which we have done with attention to ASC 606-10-50-5 to 7, we note that we include the information in our press releases and our investor presentations in response to past requests for such information by users of our financial statements. On the other hand, our chief operating decision makers utilize aggregate consideration to be received from a given contract when deciding to enter those transactions and in evaluating strategic decisions, as well as when examining the financial performance of the Company. Distinctions between material and technology license streams will vary across customers and are not key decision factors when entering into contractual arrangements with our customers. As such, we believed it was appropriate to emphasize in those filings the key indicator as used by our decision makers in developing those transactions, aggregate revenue comprised of total consideration derived from those such contracts. However, in consideration of the continued use of this disaggregation of material sales and royalty and license fees by readers of our press releases and investor presentations, we will also present this disaggregation in future filings.

Read in the reply
In its next report

First report after the company's reply of Nov 23, 2020: 10-K filed Feb 18, 2021 ↗, against the 10-K filed Feb 20, 2020 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2020-12-01

Form 10-K for the fiscal year ended December 31, 2016

2017-07-05 to 2017-07-27 · 1 question · 1 letter from the SEC, 1 from the company
Review closed 2017-07-27
SEC asked
Please tell us the reasons that phosphorescent emitter demand was higher for developmental material sales. Also, tell us the reasons for the changes in gross margin percentage for developmental material sales, and why your discussion of gross margin percentage is limited to commercial material sales. Include in your response your analysis of whether these issues should be addressed your Form 10-Q.
OLED answered
For sake of clarity, we are answering the Staff’s comment in two parts, as follows:

United States Securities and Exchange

Commission

1) Please tell us the reasons that phosphorescent emitter demand was higher for developmental material sales.

In most cases, when developing new generations of emitters, a structured process development and scale up sequence is followed. We classify development material sales as sales of phosphorescent emitter material that are “pre-commercial,” that is, in early-stage development through to “final validation” batch status within this sequence.
Rest of the answer

Multiple sample-sized lots of increasing volumes are developed and sold to customers, eventually leading up to the commercial-sized batches required by the customers’ production processes. Once we validate the phosphorescent emitter material, we classify subsequent sales of the emitters as commercial material sales.

Development material sales will vary from quarter to quarter based on the life cycle of our customers’ existing products and new product pipeline; however, we expect that on an annual basis, development material sales will not be a significant percent of total material sales as OLED technologies obtain expanded usage in the display marketplace.

In the first quarter of 2017, we had several emitters that were in the latter stages of the development cycle prior to transitioning to commercial batch validation, compared to minimal such activity in the first quarter of 2016. As the volume of the sample size increases during the development cycle, latter-stage samples are larger. This accounted for the sizable increase in development material sales volume in the first quarter of 2017 as compared to the first quarter of 2016.

Read in the reply

Also in this review: closing letter, 2017-07-27

Form 10-K

2016-07-13 to 2016-07-21 · 4 questions · 1 letter from the SEC, 1 from the company
Review closed 2016-07-21
Non-GAAP measuresIncome taxesInventoryResults discussion (MD&A)
Form 10-K for the Fiscal Year Ended December 31, 2015 · Item 6. Selected Financial Data, page 29
SEC asked (1)
We note that you present non-GAAP measures for various financial statement line items, including cost of material sales, operating expenses, operating income, income before income taxes, net income and net income per basic and diluted common share.
Rest of the question

Each non-GAAP measure should be accompanied by a separate reconciliation of the differences between the disclosed measure and the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP. Please refer to the guidance in Item 10(e)(1)(i)(B) of Regulation S-K and revise future filings to include the required reconciliations.

OLED answered
In future filings, the Company will provide separate reconciliations to accompany each non-GAAP measure to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP.
Read in the reply
In its next report

First report after the company's reply of Jul 20, 2016: 10-Q filed Aug 4, 2016 ↗, against the 10-Q filed May 5, 2016 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Form 10-K for the Fiscal Year Ended December 31, 2015 · Item 6. Selected Financial Data, page 29
SEC asked (2)
In addition, please revise your future filings to correctly and consistently label your non- GAAP measures. For example, on page 29 you present the non-GAAP measures adjusted net income and adjusted net income per basic and diluted common share while on page 30 you present the same non-GAAP amounts labelled as net income and net income per common share. Refer to Item 10(e)(1)(ii)(E) of Regulation S-K.
OLED answered
In future filings, the Company will revise the labels of non-GAAP measures to ensure that they are consistent.
Read in the reply
In its next report

First report after the company's reply of Jul 20, 2016: 10-Q filed Aug 4, 2016 ↗, against the 10-Q filed May 5, 2016 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Form 10-K for the Fiscal Year Ended December 31, 2015 · Item 6. Selected Financial Data, page 29
SEC asked (3)
We note that you disclose non-GAAP measures that adjust your cost of material sales, operating expenses, operating income, income before income taxes, net income and net income per common share information to remove the impact of an inventory write-down during 2015.
Rest of the question

From your disclosures on page 36 we note that you had inventory writedowns in both 2015 and 2014 but you chose to remove the impact of the inventory writedown and related tax effect in the non-GAAP measures for 2015 only and did not include similar non-GAAP disclosures that reflected the impact of inventory write-downs in 2014. Accordingly, your 2015 non-GAAP measures may be inconsistent with Rule 100(b) of Regulation G as well as Question 100.02 of the updated Compliance and Disclosure Interpretations issued on May 17, 2016. Please review this guidance when preparing your future filings.

OLED answered
In future filings, the Company will ensure that its disclosures are consistent with Rule 100(b) of Regulation G as well as Question 100.02 of the updated

Compliance and Disclosure Interpretations issued on May 17, 2016.
Read in the reply
In its next report

First report after the company's reply of Jul 20, 2016: 10-Q filed Aug 4, 2016 ↗, against the 10-Q filed May 5, 2016 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Form 10-K for the Fiscal Year Ended December 31, 2015 · Item 6. Selected Financial Data, page 29
SEC asked (4)
Revise your future filings to provide a more robust discussion of the reasons why management believes the presentation of each non-GAAP measure provides useful information to investors regarding your financial condition and results of operations. Please refer to the guidance in Item 10(e)(1)(i)(C) and (D) of Regulation S- K.
OLED answered
In future filings, the Company will provide more robust discussion of why management believes each non-GAAP measure provides useful information to investors regarding the Company’s financial condition and results of operations.

Furthermore, the Company hereby acknowledges that:

• the Company is responsible for the adequacy and accuracy of the disclosure in the filing;

Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and the Company may not assert Staff comments as a defense in any
Rest of the answer

proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Read in the reply
In its next report

First report after the company's reply of Jul 20, 2016: 10-Q filed Aug 4, 2016 ↗, against the 10-Q filed May 5, 2016 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2016-07-21

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 12 letters filed since 2016-07-13. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OLED/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.